Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Series C round grosses $65mm for aesthetics company Sientra

Executive Summary

New investor Abingworth Management led a $65mm Series C financing for Sientra Inc. (implantable devices for cosmetic and reconstructive surgery). Returning shareholders also joined, including Clarus Ventures and OrbiMed Advisors. The money will support marketing activities for the company’s Silimed portfolio of silicone gel breast implants, approved by the FDA in early March.
Deal Industry
  • Medical Devices
    • Implantable Devices
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies

Advertisement
UsernamePublicRestriction

Register